Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

BAO PHARMA-B(02659.HK)

Event Tracking

Apr17

BioTech Pharma's Recombinant Ulinastatin Clinical Trial Application Accepted by NMPA

07:33

Apr16

Baoji Pharmaceutical's KJ017 Approved for Market, Driving Valuation Recovery in Hong Kong's Biopharmaceutical Sector

05:42

Apr9

Chinese Innovative Drug Industry Experiences a Value Reappraisal, Baoyi Pharmaceutical Benefits from Favorable Policies

05:49

Apr8

Shanghai Bioej Pharmaceutical Obtains Marketing Approval for KJ017 Human Hyaluronidase Injection

04:01

Mar26

BAO PHARMA-B released FY2025 Annual Earnings on March 26, 2026 (BJT), with actual revenue of HKD 53.73 M and EPS of HKD -1.4886

15:00

BAO PHARMA-B released FY2025 Q4 earnings on March 26, 2026 (BJT) with actual revenue HKD 0 and actual EPS HKD 0

15:00

Schedules & Filings

Schedules

Filings

Mar26

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 3.984 M, Net Income -117.99 M, EPS -0.4034

Dec10

IPO(CST)

Listing Price HKD 26.38

Dec2

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 22.98 M, Net Income -100.2 M, EPS -0.3478

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

BAO PHARMA-B(02659.HK)

BAO PHARMA-B Stock Performance Chart